Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of$ 1.43 per share. This compares to earnings of $1.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.20%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of$ 1.54 per share when it actually produced earnings of $1.77, delivering a surprise of 14.94%.Over the ...